Evidence map›Paper›PMID 28900355›Full record

ArticleJournal of preventive medicine and hygiene2017

Distribution of

A Peymani, T Naserpour-Farivar, E Zare, K H Azarhoosh

Open access · greenAbstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Distribution of blaScientific reports · 2023
    Article
  8. Article
  9. Article
  10. Infection and drug resistance · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Detection of Extended-Spectrum β-Lactamases amongEthiopian journal of health sciences · 2021
    Article
  15. Virulence and resistance determinants inJournal of advanced veterinary and animal research · 2020
    Article
  16. Occurrence ofMicroorganisms · 2020
    Article
  17. Prevalence and Molecular Typing of Colistin-ResistantInfection and drug resistance · 2020
    Article
  18. Distribution ofAntimicrobial resistance and infection control · 2019
    Article
  19. Article
  20. Prevalence of antibiotic resistance and virulent factors in nosocomial clinical isolates of Pseudomonas aeruginosa from Panamá.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

A PeymaniMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
T Naserpour-FarivarMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
E ZareMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
K H AzarhooshMedical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Qazvin University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPseudomonas aeruginosa is as an important opportunistic human pathogen, which is associated with several clinical infections that are usually difficult to treat because of resistance to multiple antimicrobials. The production of extendedspectrum ß-lactamases (ESBLs) is an important mechanism of ß-lactam resistance. The aims of this study were to determine the prevalence of ESBLs, antimicrobial susceptibility, and to detect the bla

methodsIn this study, carried out from March 2013 to December 2014, 266 P. aeruginosa isolates were collected from patients admitted to teaching hospitals of Qazvin and Tehran, Iran. All isolates were initially screened for ESBL production by disk diffusion method and were further confirmed using a combined disk method. Antimicrobial susceptibility of ESBL-producing isolates was determined by standard disk diffusion method. Polymerase Chain Reaction (PCR) and sequencing techniques were employed for detection of bla

resultsIn total, 262 (98.5%) P. aeruginosa isolates were nonsusceptible to the used extended spectrum cephalosporins, and, among these, 75 (28.6%) isolates were ESBL producers. Fifty-nine (78.7%) of ESBL-producing isolates showed multidrug-resistance pattern. Of 75 ESBL-positive isolates, the bla

conclusionsThe results of this study showed the notable prevalence of ESBLs among the clinical isolates of P. aeruginosa in Iran, indicating the urgency for the implementation of appropriate follow-up measures for infection control and proper administration of antimicrobial agents in our medical settings.

Indexed as

beta-Lactam ResistanceAnti-Bacterial Agentsbeta-LactamasesFemaleHospitalsHumansIranMaleMicrobial Sensitivity TestsPolymerase Chain ReactionPseudomonas aeruginosaAnti-Bacterial Agentsbeta-LactamasesblaCTX-MblaSHVblaTEMESBLPseudomonas aeruginosa

Identifiers

PMID28900355
PMCPMC5584084
OpenAlexW2744145902

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.